Related Experiment Video
Updated: Apr 21, 2026
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
The axis of progression of disease
1Pathology Department and Cell Biology Program, Case Western Reserve University, Cleveland, OH, USA.
Abstract:
Starting with genetic or environmental perturbations, disease progression can involve a linear sequence of changes within individual cells. More often, however, a labyrinth of branching consequences emanates from the initial events. How can one repair an entity so fine and so complex that its organization and functions are only partially known? How, given the many redundancies of metabolic pathways, can interventions be effective before the last redundant element has been irreversibly damaged? Since progression ultimately proceeds beyond a point of no return, therapeutic goals must target earlier events. A key goal is therefore to identify early changes of functional importance. Moreover, when several distinct genetic or environmental causes converge on a terminal phenotype, therapeutic strategies that focus on the shared features seem unlikely to be useful - precisely because the shared events lie relatively downstream along the axis of progression. We therefore describe experimental strategies that could lead to identification of early events, both for cancer and for other diseases.
Insights
Identifying early cellular changes is crucial for effective disease treatment. This study proposes experimental strategies to pinpoint these critical early events before irreversible damage occurs.
Area of Science:
- Cellular biology
- Disease progression
- Therapeutic strategies
Background:
- Disease progression often involves complex, branching cellular changes rather than linear sequences.
- Understanding and intervening in these intricate pathways is challenging due to cellular complexity and metabolic redundancy.
- Current therapeutic strategies may be limited if they target downstream events rather than early, critical changes.
Purpose of the Study:
- To address the challenge of intervening in complex disease progression.
- To identify key experimental strategies for detecting early, functionally important cellular changes.
- To develop approaches for targeting diseases, including cancer, at their earliest stages.
Main Methods:
- The study outlines experimental strategies for identifying early events in disease progression.
- Focus is placed on detecting changes that are functionally significant at the cellular level.
- The proposed methods aim to be applicable to both cancer and other complex diseases.
Main Results:
- The abstract does not contain specific results but proposes a framework for identifying them.
- The described strategies are designed to overcome the complexities of branching cellular pathways.
- The focus is on early detection to enable timely and effective therapeutic intervention.
Conclusions:
- Identifying early events is essential for successful disease intervention.
- Experimental strategies are needed to detect these critical early changes.
- Targeting early events offers a more promising therapeutic approach for complex diseases.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
01:17Introduction to Language of Pathophysiology ll
01:26Stages of Infection
01:24Parkinson Disease ll: Pathophysiology
01:29Alzheimer Disease l: Introduction